The UK's advertising watchdog has ruled against several companies advertising oral GLP-1 weight loss medications to the UK ...

The new space complements established solid-phase synthesis operations, giving Agilent's Advanced Therapeutics Division a dedicated environment to develop solvent-free enzymatic manufacturing approach ...

The €29m ATLab site will target up to 10,000 doses annually and its two-hour proximity to major European airports meets the critical 24-hour production-to-administration window imposed by lead-212's ...

The two-day programme addresses practical barriers to sustainable procurement, manufacturing and packaging — with ...

Learn why early notified-body engagement is critical for combination products, including design rationale, risk controls, validation evidence and traceable documentation ahead of submission.

Piramal Pharma Solutions (PPS) is to invest more than $5.3m in upgrading its drug substance manufacturing site in Aurora, ...

This new technology platform addresses stability, concentration, and delivery challenges in biologics, including new ...

The accelerated pathway extends the CDMO's Rapid Antibody framework to bispecifics and next-generation formats — targeting ...

At Booth 11F93 in Hall 11, the company will not only be showcasing its new look, it will also present solutions for sensitive ...

Tablet coating defects rarely begin at the coating stage. In this live webinar, industry expert Fred Rowley examines the ...

Partnership combines complementary expertise to help pharmaceutical formulators address complex solid oral dose development ...

The expansion includes new fluorinated sugars and GMP-grade Poly(I:C), supporting glycoengineering, bioproduction, vaccine ...